Viewing Study NCT03239860

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-06-20 @ 2:53 PM
Study NCT ID: NCT03239860
Status: TERMINATED
Last Update Posted: 2020-10-20
First Post: 2017-07-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis
Sponsor: GeNeuro SA
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis, Relapsing-Remitting View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Sclerosis View
None Multiple Sclerosis Relapsing-Remitting View
None GNbAC1 View
None MRI View
None Monoclonal antibody View
None Multiple Sclerosis associated retrovirus MSRV View
None MS View
None RRMS View
None HERV-W View
None Temelimab View